Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1991-05-14
1992-09-08
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514274, 514392, 514419, 544316, 548318, 548414, 548483, 548492, A61K 3140, A61K 31415, C07D20918, C07D40304
Patent
active
051458454
ABSTRACT:
The present invention relates to novel compounds, which are derivatives of ureas, thioureas, carbamates, sulfonylureas, sulfonamides, amides, and thioamides of 2-carboxyindoles as illustrated by the formula ##STR1## The invention also relates to methods for the preparation of the novel compounds, as well as to pharmaceutical compositions or methods of use for the novel compounds. More specifically, the compounds of the present invention are useful in the treatment of neurodegenerative disorders including cerebrovascular disorders as well as in the treatment of schizophrenia or epilepsy; and as analgesics and anxiolytics.
REFERENCES:
patent: 3182071 (1965-05-01), Shavel et al.
patent: 3364224 (1968-01-01), Shavel et al.
patent: 3472870 (1969-10-01), Larsen et al.
patent: 3574737 (1971-04-01), Grigst et al.
patent: 4960786 (1990-10-01), Salituro et al.
patent: 4980368 (1990-12-01), Thielke et al.
Russo et al., Farmaco, Ed. Sci., 43(5), pp. 409-420, 1988.
R. Schwarcz, et al., The Lancet, pp. 140-143 (1985).
Choi, Neuron. 1:623-634 (1988).
B. Meldrun, "Neurotoxins and Their Pharmacological Implications" edited by P. Jenner, Raven Press, New York pp. 34-53 (1987).
J. W. McDonald, et al., Eur. J. Pharmocol., 140:359-361 (1987).
J. F. Church, et al., Anesthesiology 69:702-709 (1988).
R. Gill, et al, J. Neurosci. 7:3343-3349 (1987).
S. M. Rothman, et al., Neurosci., vol. 21, No. 3, pp. 673-678 (1987).
Gray et al., J. Med. Chem., vol. 34, No. 4, pp. 1283-1292 (1991).
M. P. Goldberg, et al., Neurosci. Lett. 80:11-15 (1987).
Leeson et al., J. Med. Chem., vol. 34, No. 4, pp. 1243-1252 (1991).
J. A. Kemp, et al., TIPS 8:414-415 (1987).
R. Gill, et al., J. Neurosci. vol. 21, No. 3, pp. 847-855 (1988).
C. K. Park, et al., Ann. Neurol. 24 No. 4, pp. 543-551 (1988).
G. K. Steinberg, et al., Stroke 19:1112-1118 (1988).
Abstract No. 9, paper entitled "Novel Glycine Antagonists" presented Apr. 1991 at 201st Annual American Chemical Soc. Meeting.
PCT Gazette, Section 1, No. 9, WO91/04973, p. 3184 (1991).
Johnson Graham
Malone Thomas C.
Yuen Po-Wai
Morris Patricia L.
Thierstein Joan
Warner-Lambert Co.
LandOfFree
Substituted 2-carboxylindoles having pharmaceutical activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-carboxylindoles having pharmaceutical activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-carboxylindoles having pharmaceutical activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-134428